Literature DB >> 5645686

Phenylketonuria. Mass screening of newborns in Ireland.

S F Cahalane.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5645686      PMCID: PMC2019828          DOI: 10.1136/adc.43.228.141

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  15 in total

1.  MATERNAL PHENYLKETONURIA. A CAUSE OF MENTAL RETARDATION IN CHILDREN WITHOUT THE METABOLIC DEFECT.

Authors:  C C MABRY; J C DENNISTON; T L NELSON; C D SON
Journal:  N Engl J Med       Date:  1963-12-26       Impact factor: 91.245

2.  A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS.

Authors:  R GUTHRIE; A SUSI
Journal:  Pediatrics       Date:  1963-09       Impact factor: 7.124

3.  PHENYLKETONURIA: A REPORT ON THE GUTHRIE SCREENING TEST.

Authors:  S F CAHALANE
Journal:  J Ir Med Assoc       Date:  1964-03

4.  Atypical phenylketonuria in sisters with normal offspring.

Authors:  L I WOOLF; C OUNSTED; D LEE; M HUMPHREY; N M CHESHIRE; G R STEED
Journal:  Lancet       Date:  1961-08-26       Impact factor: 79.321

5.  The birthplaces of parents and grandparents of a series of patients with phenylketonuria in in south-east England.

Authors:  C O CARTER; L I WOOLF
Journal:  Ann Hum Genet       Date:  1961-05       Impact factor: 1.670

6.  Variations in intelligence in phenylktonuria.

Authors:  M W PARTINGTON
Journal:  Can Med Assoc J       Date:  1962-04-21       Impact factor: 8.262

7.  Diagnosis and treatment: interpreting the positive screening test in the newborn infant.

Authors:  C R Scriver
Journal:  Pediatrics       Date:  1967-05       Impact factor: 7.124

8.  Screening program for early detection of phenylketonuria in the newborn in Israel.

Authors:  B E Cohen; A Szeinberg; I Peled; B Szeinberg; R Bar-Or
Journal:  Isr J Med Sci       Date:  1966 Mar-Apr

9.  Atypical phenylketonuric heterozygote. Deficiency in phenylalanine hydroxylase and transaminase activity.

Authors:  J A Anderson; R Fisch; E Miller; D Doeden
Journal:  J Pediatr       Date:  1966-03       Impact factor: 4.406

10.  Diagnostic and therapeutic implications of persistent hyperphenylalaninemia in an infant heterozygous for the gene of phenylketonuria.

Authors:  A J Schneider; S D Garrard
Journal:  J Pediatr       Date:  1966-05       Impact factor: 4.406

View more
  13 in total

1.  Screening for phenylketonuria.

Authors: 
Journal:  Can Med Assoc J       Date:  1968-07-27       Impact factor: 8.262

2.  Phenylketonuria: outcome and problems in a "diet-for-life" clinic.

Authors:  E R Naughten; B Kiely; I Saul; D Murphy
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

3.  The heterozygote advantage in phenylketonuria.

Authors:  L I Woolf
Journal:  Am J Hum Genet       Date:  1986-05       Impact factor: 11.025

Review 4.  Phenylketonuria and its variations. A review of recent developments.

Authors:  M E Blaskovics; T L Nelson
Journal:  Calif Med       Date:  1971-07

5.  Problems of phenylketonuria.

Authors: 
Journal:  Br Med J       Date:  1971-12-18

6.  Mass screening of the newborn for metabolic disease.

Authors:  L I Woolf
Journal:  Arch Dis Child       Date:  1968-04       Impact factor: 3.791

7.  The search for phenylketonuria.

Authors: 
Journal:  Can Med Assoc J       Date:  1969-08-23       Impact factor: 8.262

8.  Ethnic variation in genetic disease: possible roles of hitchhiking and epistasis.

Authors:  D K Wagener; L L Cavalli-Sforza
Journal:  Am J Hum Genet       Date:  1975-05       Impact factor: 11.025

9.  Liver phenylalanine hydroxylase activity in relation to blood concentrations of tyrosine and phenylalanine in the rat.

Authors:  M M McGee; O Greengard; W E Knox
Journal:  Biochem J       Date:  1972-05       Impact factor: 3.857

10.  Screening for congenital hypothyroidism in the Republic of Ireland.

Authors:  S Dockeray; S F Cahalane; M Brody; C Mullins; M J Cullen
Journal:  Br Med J       Date:  1980-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.